The incidence and characteristics of VTE within 100 days of CAR T-cell therapy

Ann Hematol. 2023 Mar;102(3):683-685. doi: 10.1007/s00277-023-05104-w. Epub 2023 Jan 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Incidence
  • Risk Factors
  • Venous Thromboembolism* / epidemiology